01 1Sterling Spa
01 1DEFLAZACORT
01 1Italy
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2023-03-08
Pay. Date : 2023-03-06
DMF Number : 30313
Submission : 2016-03-02
Status : Active
Type : II
20
Sterling Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Global leader in steroidal APIs
One of their notable products is DEFLAZACORT, with a corresponding US DMF Number 30313.
Remarkably, this DMF maintains an Active status since its submission on March 02, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 08, 2023, and payment made on March 06, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
